Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor

Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor

US Patent 12453735 · Granted Oct 28, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating non-alcoholic steatohepatitis with cck inhibitors2025
Compositions and methods for preventing tumors and cancer2024
Compositions and methods for inducing humoral and cellular immunities against tu2024
Nanoparticle to target cancer2023
Compositions and methods for inducing humoral and cellular immunities against tu2023
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Nanoparticle to target cancer2022
Combinatorial therapies for the treatment of neoplasias using the opioid growth 2020
Electronic storage system2019